3 ms·
The March 23 press release Pfizer Initiates Phase 1 Study of Novel Oral Antiviral Therapeutic Agent Against SARS-CoV-2 https://www.pfizer.com/news/press-releas
by sradman 5y ago
The March 23 press release Pfizer Initiates Phase 1 Study of Novel Oral Antiviral Therapeutic Agent Against SARS-CoV-2
https://www.pfizer.com/news/press-release/press-release-detail/pfizer-initiates-phase-1-study-novel-oral-antiviral https://www.pfizer.com/news/press-release/press-release-deta...